Primary Record
Tulathromycin B
- In stock
- 2,624 g
- Purity
- 99.4 %
- CAS
- 280755-12-6
Compound Identifiers & Properties
- CAS
- 280755-12-6
- PubChem CID
- 71244897
- SMILES
- CCCNC[C@@]1([C@@H](O[C@H](C[C@@]1(C)OC)O[C@H]2[C@@H]([C@H]([C@](C[C@H](CN[C@@H]([C@@H](OC(=O)[C@@H]2C)[C@@](C)([C@@H](CC)O)O)C)C)(C)O)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)C)C)O
- Canonical SMILES
- CCCNC[C@]1(O)[C@H](C)O[C@@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@H]([C@](C)(O)[C@H](O)CC)OC(=O)[C@@H]2C)C[C@@]1(C)OC
Names & Synonyms
- Tulathromycin B
- Tulathromycin B [USAN]
- T5PDD839DA
- UNII-T5PDD839DA
- RefChem:192489
- Tulathromycin B - 95%
- TULATHROMYCIN B [MI]
- 280755-12-6
- TULATHROMYCIN COMPONENT B
- Tulathromycin Structural Isomer
- SCHEMBL14672083
- CHEBI:182496
- C41H79N3O12
- MSK10016-100M
- ZINC306120615
- CP-547272
- AT167464
- DA-68416
- FT152643
- CP 547272
- CP-547,272
- C21789
- Tulathromycin B Solution in Methanol, 100ug/mL
- A900910
- (2R,3R,6R,8R,9R,10S,11S,12R)-2-[(2R,3R)-2,3-dihydroxypentan-2-yl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)oxan-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one
- Q27289703
- Tulathromycin B - 5% (mixture with Tulathromycin A)
- Tulathromycin B, approximately 5per cent(As a mixture with Tulathromycin A)
- Tulathromycin B, approximately 5%(As a mixture with Tulathromycin A)
- (2R,3R,6R,8R,9R,10S,11S,12R)-11-((2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-((propylamino)methyl)-alpha-L-ribo-hexopyranosyl)oxy)-2-((1R,2R)-1,2-dihydroxy-1-methylbutyl)-8-hydroxy-3,6,8,10,12-pentamethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-4-azacyclotridecan-13-one
- (2R,3R,6R,8R,9R,10S,11S,12R)-11-((2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-((propylamino)methyl)-alpha-L-ribo-hexopyranosyl)oxy)-2-((1S,2R)-1,2-dihydroxy-1-methylbutyl)- 8-hydroxy-3,6,8,10,12-pentamethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-4-azacyclotridecan-13-one
- (2R,3R,6R,8R,9R,10S,11S,12R)-11-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-4-C-[(propylamino)methyl]-alpha-L-ribo-hexopyranosyl)oxy]-2-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one
- (2R,3R,6R,8R,9R,10S,11S,12R)-2-[(1R,2R)-1,2-dihydroxy-1-methyl-butyl]-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-8-hydroxy-11-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)tetrahydropyran-2-yl]oxy-3,6,8,10,12-pentamethyl-1-oxa-4-azacyclotridecan-13-one
- 1-Oxa-4-azacyclotridecan-13-one, 11-((2,6-dideoxy-3-C-methyl-3-O-methyl-4-C-((propylamino)methyl)-alpha-l-ribo-hexopyranosyl)oxy)-2-(1,2-dihydroxy-1-methylbutyl)-8-hydroxy-3,6,8,10,12-pentamethyl-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranosyl)oxy)-, (2S,3S,6R,8R,9R,10S,11S,12R)-